Wikidata

(Q61979131)

English

Phase 2 Study of Carfilzomib in Relapsed and Refractory Multiple Myeloma

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
An Open-label, Single-arm, Phase 2 Study of Carfilzomib in Patients With Relapsed and Refractory Multiple Myeloma (English)
0 references
sponsor
Amgen
0 references
country
Canada
0 references
start time
August 2007
0 references
end time
November 2010
0 references
number of participants
312
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61979131&oldid=2149125022"